Sunday, August 05, 2007 2:08:13 PM
If Dew saw anything 'sinister', he would have already posted.
He and others have been buying...
market sentiment is decidedly negative, that coupled with 'shock' of the NM283 hold and program termination just 1 month after the announcement of no interaction w/ ribavirin and no obvious concern NM283 safety @ that time...
In the long run, I expect it was better for NM283 to be terminated now. In addtion to the risk/ benefit analysis completed by the FDA, I am sure NVS did a cost / benefit analysis.
Bottom line... investors do not like disappointment and, at times, they have a tendency to 'throw the baby out with the bath water.'
the choices are buy, sell, or hold...
take care
The creation of a thousand forests is in one acorn.
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM